Surgical Science Sweden AB (publ)
SUSRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,201,936 | $6,077,937 | $8,537,908 | $12,288,566 |
| - Cash | $968,155 | $634,366 | $433,733 | $316,680 |
| + Debt | $56,939 | $40,023 | $14,682 | $12,071 |
| Enterprise Value | $7,290,720 | $5,483,594 | $8,118,857 | $11,983,957 |
| Revenue | $884,087 | $882,853 | $802,540 | $366,778 |
| % Growth | 0.1% | 10% | 118.8% | – |
| Gross Profit | $597,898 | $612,879 | $531,517 | $265,942 |
| % Margin | 67.6% | 69.4% | 66.2% | 72.5% |
| EBITDA | $169,651 | $214,287 | $271,295 | $115,046 |
| % Margin | 19.2% | 24.3% | 33.8% | 31.4% |
| Net Income | $131,646 | $233,972 | $187,974 | $86,248 |
| % Margin | 14.9% | 26.5% | 23.4% | 23.5% |
| EPS Diluted | 2.58 | 4.59 | 3.69 | 2.02 |
| % Growth | -43.8% | 24.4% | 82.7% | – |
| Operating Cash Flow | $137,225 | $238,291 | $129,487 | $39,083 |
| Capital Expenditures | -$47,530 | -$44,129 | -$34,548 | -$14,377 |
| Free Cash Flow | $89,695 | $194,162 | $94,939 | $24,706 |